Literature DB >> 7093909

Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling.

J S Meyer, R E Connor.   

Abstract

The thymidine labeling indice (TLI) of normal and abnormal epithelium in the human breast was measured in 108 surgical specimens. The mean values for various histologic entities were: normal lobule (0.91%; normal postlobular duct 0.71%; lobular hyperplasia 0.82%; ductal hyperplasia, lobular cell type 0.74%; intraductal hyperplasia 0.79%; papillary intraductal hyperplasia 1.02%; blunt duct adenosis 0.68%; cyst 0.56%; infiltrating carcinoma 6.82%; carcinoma in situ 5.53%. The TLI of the normal lobule declined significantly with increasing age, but that of the normal postlobular duct did not. Before the menopause, the mean TLI of the normal lobule was 1.01%, and that of the normal postlobular duct was 0.75%. After the menopause the values had declined to 0.26% and 0.41%, respectively. These findings indicated that the lobules are more sensitive to stimulation by sex steroids than the postlobular ducts. The TLIs of the various benign proliferative entities were not significantly correlated with age, and like the normal lobule and postlobular duct were near the low end of the range of TLI of breast carcinoma. Benign proliferative entities with TLIs in the high part of the breast carcinoma range were not encountered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093909     DOI: 10.1002/1097-0142(19820815)50:4<746::aid-cncr2820500420>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.

Authors:  K Christov; K L Chew; B M Ljung; F M Waldman; L A Duarte; W H Goodson; H S Smith; B H Mayall
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells.

Authors:  K Joshi; J A Smith; N Perusinghe; P Monoghan
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

3.  Comment on progesterone effects in breast tissue.

Authors:  T J Anderson; A Howell; R J King
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

4.  Thymidine labeling index in breast tumors.

Authors:  H D Lee; E Y Soh; H S Chi; B R Kim; K S Lee; K S Song; H J Jung
Journal:  Jpn J Surg       Date:  1990-03

Review 5.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 6.  Breast cancer prevention through modulation of endogenous hormones.

Authors:  D V Spicer; M C Pike
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

Authors:  R J Lellé; W Heidenreich; G Stauch; I Wecke; J Gerdes
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  Proliferative and secretory activity in the pregnant and lactating human breast.

Authors:  S Battersby; T J Anderson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma.

Authors:  Alan K Meeker; Jessica L Hicks; Edward Gabrielson; William M Strauss; Angelo M De Marzo; Pedram Argani
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

10.  Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics.

Authors:  Joaquin Chapa; Ryan J Bourgo; Geoffrey L Greene; Swati Kulkarni; Gary An
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.